No influence of BCR-ABL1 transcript types e13a2 and e14a2 on long-term survival: results in 1494 patients with chronic myeloid leukemia treated with imatinib (Q40382581)
Jump to navigation
Jump to search
scientific article published on 12 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No influence of BCR-ABL1 transcript types e13a2 and e14a2 on long-term survival: results in 1494 patients with chronic myeloid leukemia treated with imatinib |
scientific article published on 12 January 2017 |
Statements
1 reference
No influence of BCR-ABL1 transcript types e13a2 and e14a2 on long-term survival: results in 1494 patients with chronic myeloid leukemia treated with imatinib (English)
1 reference
Andreas Hochhaus
1 reference
Fausto Castagnetti
1 reference
Gabriele Gugliotta
1 reference
Michele Baccarani
1 reference
Susanne Saussele
1 reference
Markus Pfirrmann
1 reference
Joerg Hasford
1 reference
Dobromira Evtimova
1 reference
Francisco Cervantes
1 reference
Jeroen Janssen
1 reference
Verena S Hoffmann
1 reference
Rüdiger Hehlmann
1 reference
12 January 2017
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference